Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion evidence source_evidence_literature NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion SIO_000772 21147110 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion wasDerivedFrom befree-2016 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion wasGeneratedBy ECO_0000203 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- befree-2016 importedOn "2016-02-19" NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.